MA

Mohammad Asim

Active Director Additional Director DIN 11348430
DIN 11348430 First appointment Oct 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Mohammad Asim

Data last updated:

Mohammad Asim is an Additional Director at Medjool Lifesciences Private Limited (since 2025). The company operates in Pharma.

DIN 11348430
Primary Designation Additional Director
Industry Pharma
First Appointment 25 Oct 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medjool Lifesciences Private Limited U21000DL2025PTC447081
Additional Director25 Oct 2025Active

Board colleagues of Mohammad Asim

NameDINCompanyDesignation
Gulista11348570Medjool Lifesciences Private LimitedAdditional Director
Rizwan Husain11072682Medjool Lifesciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medjool Lifesciences Private Limited
Premium access

Shareholding and investment profile for Mohammad Asim

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohammad Asim

Mohammad Asim currently holds 1 directorship: Medjool Lifesciences Private Limited (Additional Director, since 25 Oct 2025).

Mohammad Asim was first appointed on 25 Oct 2025 as Additional Director at Medjool Lifesciences Private Limited.

The current boards of Mohammad Asim's companies include Gulista (Medjool Lifesciences Private Limited), Rizwan Husain (Medjool Lifesciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available